LRRK2 and Parkinson disease: Whereas LRRK2 cases present with typical clinical features of PD, at the histopathological level, the G2019S mutation is associated with a ~79% frequency of Lewy body formation, more prominent than the R1441C mutation, where Lewy bodies form in ~43% of carriers13.